Analyzing cancer imaging data from few datasets
Advanced prostate cancer treatment – if, when and what?
The use of neoadjuvant studies to prevent melanoma from recurring
MRI-based prostate cancer diagnosis: economic and logistical considerations
Case-based debate: is there evidence for local treatment in oligometastatic prostate cancer?